No nonsense or influential words to announce the next company, cannabis is a serious business and Cannabis Strategic Ventures (OTCQB: $NUGS) would like to underline that. An adequate reason to take a closer look at this company and understand what distinguishes this company in such potential sector.
Cannabis Strategic Ventures has enthusiastic investors thanks to its professional and goal-oriented nature that has enabled the brands to become true category leaders. One objective is to take the lead in defining best practices in the cannabis industry through innovation, brand development and product quality. In addition, there is a high concentration on implementing the backbone of the operational infrastructure. No semi-customization and regular calls on Cannabis Strategic Ventures to step on board and grow with their business, providing direct access to high-performing investment brands and significant transparency.
But what makes Cannabis Strategic Ventures the right company to shape the cannabis industry?
The emerging leader in the US cannabis market reported sales figures in November 2020. $6.4 million in sales were made in the quarter ended on September 30, 2020, which confirmed a serious growth was being achieved, extending broadly its positioning within the fast-growing and profitable California cannabis market.
Sales had nearly doubled from the previous quarter, with total cannabis sales reaching $3.3 million in the three months ended on June 30, 2020. Sensational, this consecutive quarterly increase of more than 90%. Which equals a year-over-year increase of more than 800% compared to the three months ended on September 30, 2019.
In particular, the explanation given for the exponential growth is the strategic vision that sets Cannabis Strategic Ventures apart from the competition. Priority is given to expansion of production, distribution and product refinement. A visible result is improved market positioning and product quality, which is due to the company’s investments in improved cultivation standards, production yield per harvest and total production capacity.
Due to the uncertain world that we currently know, many competitors decided to slow down. This created a shortage (supply) in the cannabis market, optimizing the production capacity and product quality of Cannabis Strategic Ventures. The result was a favorable unit volume and growing footprint of strong distribution relationships.
The continued supply of high-quality products to retailers in the end market increased confidence in the company and production was able to continue to increase while quality was guaranteed. Being a stable factor during a global pandemic in a fast-growing sector – where competitors took a wait-and-see approach – proved to be very effective.
Since the company announced at the end of October 2020 that it rose by more than 28% month-on-month to $2.3 million, it is interesting to see the extent to which Cannabis Strategic Ventures can rise in 2021, especially since the legalization of cannabis in the United States is gaining more interest. As long as the company maintains its effective positioning, strong product quality and a growing end-market footprint, it could just head off into a strong year.
Visit the website of Cannabis Strategic Ventures here for more information.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.